Fedenia Advisers’s Pfizer PFE Stock Holding History

Fedenia Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-164	Closed	-$3.95K	–	348
2026 Q2	$3.95K	Buy	+164	New	+$4.29K	﹤0.01%	404
2025 Q1	–	Sell	-1,840	Closed	-$48.8K	–	333
2024 Q4	$48.8K	Buy	+1,840	New	+$49.9K	0.03%	253

Other funds holding PFE

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Fedenia Advisers's PFE Position: Q3 2026 in Review

Fedenia Advisers sold out of Pfizer (PFE) in Q3 2026, closing a stake of 164 shares — an estimated $3.95K sold.

Fedenia Advisers first reported a position in PFE in Q4 2024 and held it in 2 quarters. The position peaked at $48.8K in Q4 2024. 1,907 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Fedenia Advisers reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
Fedenia Advisers sold 164 Pfizer shares in Q3 2026, an estimated $3.95K.
Fedenia Advisers first reported a position in Pfizer in Q4 2024 and held it in 2 quarters.
Fedenia Advisers's Pfizer position peaked at $48.8K in Q4 2024.
1,907 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Fedenia Advisers's 13F filing for Q3 2026, filed 22 Oct 2026.